ARTICLE
TITLE

Expression of E-Cadherin/Beta-Catenin in Epithelial Carcinomas of the Thyroid Gland

SUMMARY

BACKGROUND: The aberrant activation of Wnt signalling pathway may be a common denominator for the development of thyroid tumorigenesis. It was announced that the loss of E-cadherin rather than ß-catenin mutation represents a crucial event in determining the degree of differentiation of thyroid carcinomas.AIM: The aim of the study was to evaluate the expression of E-cadherin and ß-catenin in the thyroid cancer tissue and to correlate these data with some histological and clinical parameters of the tumours.MATERIAL AND METHODS: We investigated 112 patients, having thyroid tumours – papillary, follicular, anaplastic and oncocytic carcinomas immunohistochemically with antibodies against E-cadherin and ß-catenin. Survival analyses were done.RESULTS: E-cadherin expression was focally retained in the tumour cell membranes and the tumour cell cytoplasm of the papillary, follicular and oncocytic thyroid cancers, weather in anaplastic cancers it was almost lost (p = 0.0042, and ? = 0.019, respectively, Fisher's Exact Test). The expression of ß-catenin in tumour cytoplasm and membrane in papillary cancers was higher as compared to that in the other tumours (p = 0.111, and ? = 0.0104, respectively).CONCLUSION: Not surprisingly, the presence of aberrant expression of E-cadherin and ß-catenin in thyroid cancer has been associated with better patients' prognosis and better differentiated tumour histology.

 Articles related

Ahmed Abdel Hadi, Ali El Hindawi, Amal Hareedy, Heba Khalil, Ranya Al Ashiry, Shady Elia, Ahmed Sadek, Mona Magdy, Rafatt Atta, Amgad Anas, Hisham Bakr, Olfat Hammam (Author)    

AIM: Amplification of the Her2/neu gene and overexpression of the Her2/neu protein in gastric carcinoma (GC) is a golden criterion for target therapy with trastuzumab (Herceptin). We aim to evaluate the immunohistochemical protein expression and amplific... see more


Rahat Sarfaraz, Atika Masood, Saima Zaki, Amira Shami, Saba khaliq, Nadia Naseem    

Background & Objectives: Serous ovarian carcinoma (SOC) is characterized by extreme genomic instability, chromosomal rearrangements and copy number variations (CNVs) leading to the development of early metastasis and chemo-resistance. The present stu... see more


Xianhui Su, Xuewen Sun, Ying Wang, Yanhui Kang, Yuna Dai    

Objectives: To investigate the clinical effects of TP-based hyperthermic intraperitoneal chemotherapy (HIPEC) on the levels of antigen cluster protein 133 (CD133) and human epididymal secretory protein 4 (HE4) in patients with advanced epithelial ovarian... see more


Aprilia Indra Kartika,SN Chasanah,AS Fitriawan,DS Tanjung,MS Ftria,FK Pakun,R Oktriani,A Trirahmanto,H Prajatmo,T Aryandono,SM Haryana    

ABSTRACT Epithelial Ovarian Cancer (EOC) is malignant cancer that caused death for most women in Indonesia. The emergence of EOC showed no specific symptoms in its early stages; that makes the screening mostly occur when patients are in advanced stage. T... see more


AS. Fitriawan,SN Chasanah,FK Pakun,AI Kartika,R. Oktriani,A. Trirahmanto,H. Prajatmo,A. Ghozali,T. Aryandono,SM. Harjana    

Epithelial Ovarian Cancer (EOC) is the most lethal gynecological malignancies among woman. The majority of this disease is diagnosed at the advanced stage due to lack of specific symptoms and effective screening methods. Therefore, an adequate biomarker ... see more